Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Beck

Showing results (181-190 of 233) with videos related to

Pageof 24
Sort By:
European Journal of Pediatrics|November 1, 2011
The role of enzyme replacement therapy in severe Hunter syndrome-an expert panel consensusJoseph Muenzer, Olaf Bodamer, Barbara Burton, et al.
Journal of the American Society of Nephrology : JASN|April 10, 2009
Agalsidase alfa and kidney dysfunction in Fabry diseaseMichael West, Kathy Nicholls, Atul Mehta, et al.
Clinical Nuclear Medicine|February 6, 2018
SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate CancerChristian Schmidkonz, Michael Cordes, Michael Beck, et al.
Orphanet Journal of Rare Diseases|June 9, 2012
A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlationsAndreas Herzog, Ralf Hartung, Arnold J J Reuser, et al.
Health and Quality of Life Outcomes|September 21, 2012
Measuring patient experiences in Fabry disease: validation of the Fabry-specific Pediatric Health and Pain Questionnaire (FPHPQ)Uma Ramaswami, Donald E Stull, Rossella Parini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 5, 2018
<sup>68</sup>Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancerChristian Schmidkonz, Michael Cordes, Daniela Schmidt, et al.
Journal of Biomechanics|September 2, 2018
Effect of guided bone regeneration on bone quality surrounding dental implantsTrenton B Johnson, Ben Siderits, Seth Nye, et al.
Clinical Nuclear Medicine|June 20, 2018
Assessment of Treatment Response by 99mTc-MIP-1404 SPECT/CT: A Pilot Study in Patients With Metastatic Prostate CancerChristian Schmidkonz, Michael Cordes, Michael Beck, et al.
European Journal of Pediatrics|November 27, 2007
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapyJ Edmond Wraith, Maurizio Scarpa, Michael Beck, et al.
Human Mutation|May 28, 2009
GM1 gangliosidosis and Morquio B disease: expression analysis of missense mutations affecting the catalytic site of acid beta-galactosidaseDoris Hofer, Karl Paul, Katrin Fantur, et al.
Pageof 24

Showing results (181-190 of 233) with videos related to

Sort By:
Pageof 24
European Journal of Pediatrics|November 1, 2011
The role of enzyme replacement therapy in severe Hunter syndrome-an expert panel consensusJoseph Muenzer, Olaf Bodamer, Barbara Burton, et al.
Journal of the American Society of Nephrology : JASN|April 10, 2009
Agalsidase alfa and kidney dysfunction in Fabry diseaseMichael West, Kathy Nicholls, Atul Mehta, et al.
Clinical Nuclear Medicine|February 6, 2018
SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate CancerChristian Schmidkonz, Michael Cordes, Michael Beck, et al.
Orphanet Journal of Rare Diseases|June 9, 2012
A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlationsAndreas Herzog, Ralf Hartung, Arnold J J Reuser, et al.
Health and Quality of Life Outcomes|September 21, 2012
Measuring patient experiences in Fabry disease: validation of the Fabry-specific Pediatric Health and Pain Questionnaire (FPHPQ)Uma Ramaswami, Donald E Stull, Rossella Parini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 5, 2018
<sup>68</sup>Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancerChristian Schmidkonz, Michael Cordes, Daniela Schmidt, et al.
Journal of Biomechanics|September 2, 2018
Effect of guided bone regeneration on bone quality surrounding dental implantsTrenton B Johnson, Ben Siderits, Seth Nye, et al.
Clinical Nuclear Medicine|June 20, 2018
Assessment of Treatment Response by 99mTc-MIP-1404 SPECT/CT: A Pilot Study in Patients With Metastatic Prostate CancerChristian Schmidkonz, Michael Cordes, Michael Beck, et al.
European Journal of Pediatrics|November 27, 2007
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapyJ Edmond Wraith, Maurizio Scarpa, Michael Beck, et al.
Human Mutation|May 28, 2009
GM1 gangliosidosis and Morquio B disease: expression analysis of missense mutations affecting the catalytic site of acid beta-galactosidaseDoris Hofer, Karl Paul, Katrin Fantur, et al.
Pageof 24